| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $41.6M | +21.5% |
| R&D Expense | $63.1M | +13.0% |
| SG&A Expense | $20.8M | +1.8% |
| Operating Income | -$83.9M | -10.0% |
| Income Tax | $2K | +0.0% |
| Net Income | -$75.8M | -6.4% |
| EPS (Basic) | -$3.95 | +19.2% |
| EPS (Diluted) | -$3.95 | +19.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.7M | -59.9% |
| Current Assets | $34.6M | -54.3% |
| Total Assets | $35.8M | -55.2% |
| Current Liabilities | $13.2M | -13.4% |
| Total Liabilities | $31.6M | +73.5% |
| Stockholders' Equity | $4.2M | -93.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.2M | -23.3% |
| Investing Cash Flow | $5K | +100.9% |
| Financing Cash Flow | $34.2M | -28.6% |